The PennZone

  • Home
  • Non-profit
  • Books
  • Entertainment
  • Music
  • Marketing
  • Health
  • Legal
  • Artificial Intelligence

Phillip A. Villanueva, MD, ABNS, is being recognized by Continental Who's Who
The PennZone/10193879

Trending...
  • Growth Story Expands: $54.6M Contract, $30M Revenue Run Rate, 800+ Customers, 50+ Patents & New AI Cybersecurity Products for Cycurion, Inc $CYCU
  • Nutriband Inc. (N A S D A Q: NTRB) Breaks Into Uncharted Territory: 52-Week High Eclipsed as Shares Surge 22% —AVERSA™ Puts Investors on High Alert
  • Mud Morganfield Bares His Soul on 7" Single, 'Deep Gospel'
Phillip A. Villanueva
MEADOWBROOK, Pa., Aug. 1, 2022 /PRNewswire/ -- Phillip A. Villanueva, MD, ABNS, is being recognized by Continental Who's Who as a Distinguished Healthcare Professional for his professional excellence in Neurosurgery and his excellent work with Temple University Hospital.

A highly trained neurosurgeon with 47 years of experience in his field, Dr. Villanueva specializes in surgeries for brain injuries and neuro-critical care. In addition, he treats aneurysms and all secondary issues regarding these afflictions. The doctor also oversees the Neuroscience ICU, consulting with neurologists. For the past eight years, he has served as the Director of Neuro Trauma and Critical Care at Temple University Hospital in Philadelphia, PA. He additionally serves as a Professor of Clinical Neurosurgery at the Lewis Katz School of Medicine at Temple University.

In pursuit of his medical career, Dr. Villanueva obtained a Bachelor of Science with a double major in biology and chemistry and a minor in theology and philosophy from Biscayne College (St. Thomas University). He earned his Medical Degree from the University of Miami Miller School of Medicine. He completed his general surgery internship and neurosurgery residency after medical school at the University of Miami, Jackson Memorial Medical Center. The doctor is board certified in neurological surgery, with additional certification in neuro-critical care.

More on The PennZone
  • NYC Banners Delivers High-Stakes UN General Assembly Backdrop for the US Department of State Event
  • OneVizion Appoints Energy Infrastructure Executive Walt Farrell to Board of Directors
  • Tampa Bay Reporter Launches with a Mission to Deliver Local News with National Reach
  • "JACKIE the STRIPPER," Starring Charlotte Kirk and The PUSSYCAT DOLLS' Kimberly Wyatt, Now Streaming on PRIME
  • Migguel Anggelo Celebrates the Immigrant Experience, Latino Identity, and the Power of Iconic Latin Rhythms During Hispanic Heritage Month

Distinguished as a Fellow of the American Association of Neurological Surgeons, the doctor is board-certified in neurological surgery by the American Board of Neurological Surgery. Dr. Villanueva is a member of the American Association of Neurological Surgeons, where he sits on the subcommittee for neuro-critical care.

The doctor has increased community awareness of brain trauma outside of his neurology practice through an informative series of public service announcements. In recognition of his excellence in his field, Dr. Villanueva has been the recipient of the Best Doctors in America®️ Award in Neurological Surgery (2019-2020) and numerous other accolades.

He would like to dedicate this honor to his mentors, Hubert Rosomoff, MD; Barth Green, MD; and Bradley Ruben, MD.

Contact: Katherine Green, 516-825-5634, [email protected]

SOURCE Continental Who's Who
Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • HuskyTail Digital Puts AI to Work Behind the Scenes to Cut Client Turnaround Time
  • AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
  • $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
  • Dave's Auto Services Launches Free Seven-Week Fall Maintenance Series for Boyertown-Area Drivers
  • P-Wave Classics to publish Thomas Holcroft's The Adventures of Hugh Trevor in three volumes, beginning 19 January
  • Ad Leverage Sponsors ServiceTitan Pantheon 2026, Supporting Education and Growth in the Home Services Industry
  • From Newcomers to Neighbors: LINC Celebrates the People Who Make the Valley Home
  • Lehigh Valley's Kellyn Featured in National Film Series Exploring the Future of Diabetes Care
  • Top 100 Golf Coach Daniel Guest and Imagen Golf Announce Partnership with Remo Golf at Fairways Golf Club
  • DBF Viewer 2000 v9.32 Adds New Control for Data Export
  • Badanamu Partners With Moonbug Entertainment In Landmark Distribution Deal
  • Exonerated Movers Launches in Philadelphia on International Wrongful Conviction Day
  • Atlas Advisors President and Founder Mike McGuire Named a 2026 Leader in Business and Finance by LVB
  • Client 1st Financial Founder Michael Fischer Recognized for Building a Relationship-Rooted Career
  • Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
  • Curtis Salgado shares a love letter to the city of Chicago and Otis Rush with new single
  • Oral statement on the situation of Chairman Lee Man-hee in pretrial detention in the Republic of Korea
  • Names Are Not Important Asks What Remains When Identity Is Stripped of Labels
  • UVIFY Brings Advanced Autonomous Systems Research to IROS 2026 in Pittsburgh
  • Mad Darbarian is available for views as a Horror Host

Popular on PennZone

  • Benny Turner Revisits Freddie King's Legacy for 50th Anniversary of His Passing - 248
  • Church Tradition Takes an Unexpected Turn at the Ford Community & Performing Arts Center - 215
  • GitKraken Names Jim Shaw CEO as Software Teams Move From AI Adoption to Multi-Agent Orchestration - 170
  • Brévant Guide Launches New National Restaurant Guide Across Canada - 138
  • VC Fast Pitch and Steamwork Ventures Bring Startup & Investor Networking Event to Santa Barbara on October 8 - 123
  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • SHI Introduces the RP-222B3S, Its Highest-Capacity 4K Pulse Tube Cryocooler
  • Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates
  • Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A!
  • Mandeville Pests May Pose Serious Health Risks for Your Family

Similar on PennZone

  • NIL Club Data Shows Brands Are Looking Beyond Follower Counts in College Sports
  • NYC Banners Delivers High-Stakes UN General Assembly Backdrop for the US Department of State Event
  • Genuine Hospitality, LLC Selected to Operate Fairfield Inn & Suites Tampa Wesley Chapel
  • Pregis to Highlight EPR Expertise, Sustainable Packaging Solutions and Live Automation Demonstrations at Pack Expo International 2026
  • Infinity Infusion Solutions Launches "Women Leading Infusion Care" Campaign for National Women in Business Month
  • HuskyTail Digital Puts AI to Work Behind the Scenes to Cut Client Turnaround Time
  • AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
  • $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
  • Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
  • Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us